Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT

Official notice

Authority: Business Energy and Industrial Strategy

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: UK

Awarded value£1published contract · exc. VAT

Awarded 10 Aug 2021no call for competition

Awarded to Pfizer Ltd

What is being bought

Published requirement description

Procurement of the Covid-19 BNT162b2 Vaccine.

CPV: Vaccines

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: UK

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 9 Sept 2021, 17:14 BST
Last source update: 9 Sept 2021, 17:14 BST
FTS notice number: 2021/S 000-022454
Classification (CPV): Vaccines
Delivery area: UK
Official registry OCID: ocds-h6vhtk-02df25 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
Published justification: The award of the contract to Pfizer is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii).

Publisher note: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £11 contract exc. VAT

Bids received 1

Contracts signed 1latest 10 Aug 2021

Awarded to	Value	Date	Status
Pfizer LtdTERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES	£1 †	—	Awarded

Contracts

TERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES · Pfizer Ltd
Signed
10 Aug 2021
Value
£1
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

Business Energy and Industrial Strategy

Contracting authorityMinistry or any other national or federal authority, including their regional or local subdivisionsGeneral public services 1 Victoria Street, London, UK, SW1H0ETContact email

Dispute resolution & review bodies

Department of Business, Energy and Industrial StrategyReview body London

Bidders & participating suppliers

1 commercial party on the notice

Pfizer LimitedAwarded supplier Kent, UK

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.